Proteomic Analysis of Neuroblastoma Microenvironment: Effect of the Host–Tumor Interaction on Disease Progression
Introduction
Neuroblastoma (NB) is recognized as a malignant solid tumor in infancy with unfortunate outcomes in many children [1]. As tumor heterogeneity contributes to challenges associated with NB treatment, an additional factor that aids in tumor progression and metastasis is the role of the host–tumor microenvironment. Multiple lines of evidence suggest complex networks of communication exist in tumor environments established by cancer cells, fibroblasts, endothelial cells, and immune cells to promote cancer growth and invasion 2, 3, 4, 5, 6, 7. Because of the importance of this element to tumorigenesis, it is clear that better understanding the interplay between NB and the host environment may lead to improvements in the treatment of this deadly disease.
To date, NB grown in cell culture has provided a great deal of information regarding this childhood tumor. Nevertheless, limitations to these methods include the inability to model the host–tumor environment accurately. For instance, proteomic evidence from our laboratory has shown protein differences when NB was cultured in traditional 2D conditions versus 3D multicellular spheroids [8]. These protein expression differences could reflect the intratumoral environment occurring within NB spheres, thus capturing a better physiologic window of an in vivo tumor as has been suggested using 3D cell culture systems 9, 10. In order to further the study of the NB–host microenvironment, we evaluated the proteomic differences between in vitro NB cells versus tumors from a progressive in vivo animal model of human NB. By comparing the protein expression changes between both systems, we sought to better depict the effect the host microenvironment plays in a growing NB tumor.
Section snippets
Cell Culture and In Vivo Preparation
The SK-N-AS human NB cell line was purchased from American Type Culture Collection (ATCC) in Bethesda, MD. The cells were propagated as a monolayer culture in sterile filtered 45% BioWhittaker Dulbecco's modified Eagle's medium (DMEM from Cambrex Bioscience, Walkersville, MD) with 4.5 g/L glucose and L-glutamine, 45% BioWhittaker HAM'S F-12 with L-glutamine (Cambrex), 10% characterized fetal bovine serum (HyClone, Logan, UT), and 1% antibiotic-antimycotic (Gibco, Carlsbad, CA). Cells were seeded
Growth of NB SK-N-AS Xenograft Tumors
To investigate the significance of the host microenvironment on NB tumor progression, we utilized an in vivo NB nude mouse model. Figure 1A–C show tumors extracted from 2-, 4-, and 5-wk time points. Mean tumor weights were 0.18 ± 0.06 g, 4.28 ± 1.22 g, and 6.77 ± 1.08 g, respectively. We clearly ascertained a progressive increase in tumor growth during the experimental time interval (Fig. 1A–C). Figure 1D shows a 4-wk NB tumor at the time of sacrifice. A large, intra-abdominal mass was readily
Discussion
NB is a lethal pediatric malignancy facing obstacles related to current outcomes of advanced stage disease. As such, strategies aimed at targeting microenvironment factors that foster tumor development, such as anti-angiogenic agents [13], have the potential to become promising adjunctive therapies for high risk NB. Moreover, because a thorough evaluation of the host–tumor relationship may help to increase our knowledge concerning factors mediating NB growth and lead to novel treatment
Acknowledgments
The authors thank the A.N.N.A. Foundation (Indianapolis, IN) for their continuous support of their research.
References (32)
- et al.
The tumor microenvironment in the post-PAGET era
Cancer Lett
(2006) - et al.
Novel peptides secreted from human neuroblastoma: Useful clinical tools?
J Pediatr Surg
(2006) Glutathione S-transferase genotypes and cancer risk
Cancer Lett
(2005)- et al.
Anticancer therapeutics: A surge of new developments increasingly target tumor and stroma
Drug Resist Update
(2007) - et al.
Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer
Clin Colorectal Cancer
(2006) - et al.
Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: Mechanism of tumorigenesis
Mol Cell Proteomics
(2006) Neuroblastoma: Biology and therapy
Oncology
(1997)- et al.
Tumors and their microenvironments: Tilling the soil
Clin Cancer Res
(2003) - et al.
Response of tumor cells to hypoxia: Role of p53 and NFkB
Mol Pathol
(1998) - et al.
Distinct role of macrophages in different tumor microenvironments
Cancer Res
(2006)
Inflammation, a key event in cancer development
Mol Cancer Res
Metastasis: Cell-autonomous mechanisms versus contributions by the tumor microenvironment
Cell Mol Life Sci
Three-dimensional neuroblastoma cell culture: Proteomic analysis between monolayer and multicellular tumor spheroids
Pediatr Surg Int
Growth of multicell spheroids in tissue culture as a model of nodular carcinomas
J Natl Cancer Inst
Cell and environment interactions in tumor microregions: The multicell spheroid model
Science
Ara-C affects formation of cancer cell DNA synthesome replication intermediates
Cancer Chemother Pharmacol
Cited by (4)
Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells
2014, Pediatric ResearchPreclinical models for pediatric solid tumor drug discovery: Current trends, challenges and the scopes for improvement
2012, Expert Opinion on Drug DiscoveryOncoproteomics of neuroblastoma: A blueprint for future progress
2010, Current ProteomicsProteomic approaches in neuroblastoma: A complementary clinical platform for the future
2009, Expert Review of Proteomics